ACAD vs AMGN: Which Stock is Better?

Side-by-side comparison of Acadia Pharmaceuticals Inc and Amgen Inc in 2026

Comparison Updated:

ACAD

Acadia Pharmaceuticals Inc

$26.29

AMGN

Amgen Inc

$331.00

Key Metrics Comparison

MetricACADAMGNWinner
Market Cap$4.45B$177.92BAMGN
P/E Ratio16.9625.57ACAD
EPS (TTM)$1.55$12.92AMGN
Revenue Growth0.1%0.1%AMGN
Gross Margin59.0%70.1%AMGN

Analyze ACAD

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ACAD or AMGN a better investment?

Comparing ACAD and AMGN: Acadia Pharmaceuticals Inc has a market cap of $4.45B while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ACAD and AMGN?

ACAD (Acadia Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ACAD or AMGN?

Based on P/E ratios, ACAD trades at a lower multiple (17.0x vs 25.6x).

Which is growing faster: ACAD or AMGN?

AMGN has higher revenue growth at 0.1% vs 0.1% for ACAD.

Which company is more profitable: ACAD or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.1% compared to 59.0% for ACAD.

Which is the larger company: ACAD or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $4.45B for ACAD.

Should I buy ACAD or AMGN in 2026?

Both ACAD and AMGN have investment merit. ACAD trades at $26.29 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ACAD and AMGN stock?

Key differences: Market Cap ($4.45B vs $177.92B), P/E Ratio (17.0x vs 25.6x), Revenue Growth (0.1% vs 0.1%), Gross Margin (59.0% vs 70.1%).

Popular Stock Comparisons